Maxim Group Downgrades Palisade Bio to Hold

Maxim Group analyst Naz Rahman downgrades Palisade Bio (NASDAQ:PALI) from Buy to Hold.

Maxim Group analyst Naz Rahman downgrades Palisade Bio (NASDAQ:PALI) from Buy to Hold.

Total
0
Shares
Related Posts